Irinotecan/5-FU/FA (I-FU) or 5-FU/FA (FU) first-line therapy in older and younger patients with metastatic colorectal cancer: Combined analysis of 2,691 patients in randomized controlled trials Meeting Abstract


Authors: Folprecht, G.; Seymour, M. T.; Saltz, L.; Douillard, J. Y.; Stephens, R. J.; Van Cutsem, E.; Rougier, P.; Maughan, T. S.; Köhne, C. H.; Ironotecan Meta-analysis Group
Abstract Title: Irinotecan/5-FU/FA (I-FU) or 5-FU/FA (FU) first-line therapy in older and younger patients with metastatic colorectal cancer: Combined analysis of 2,691 patients in randomized controlled trials
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 181s
Language: English
ACCESSION: WOS:000455043700725
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.4071
Notes: Meeting Abstract: 4071 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz